AI Copilot
Portfolio
Stocks
Crypto
News
Stocks
Crypto
Chat History
Aura
Log in/ Sign up
Follow our
Join our
EN
TCRX Dividend: TScan Therapeutics Inc Yield Insights
Back
Home
Stock
TCRX
TScan Therapeutics Inc (TCRX) Price
TCRX Stock Price Chart
TCRX Financial
TScan Therapeutics Inc
$0.89
-3.79%
$-0.03
At close: Dec 18, 16:00:00 GMT-5
$0.91
2.24%
$0.02
Post-market: Dec 18, 20:00:00 GMT-5
Overview
Forecast
Earnings
Dividends
Financials
Features
AI Copilot for Stock & Crypto
Price Prediction
Fundraise Tracker
Market Sentiment
Technical Analysis
Crypto Comparison
Home Page
Trading Strategies
Megabrain Investors Picks
Trading Mindshare
Technical Signals
Pivot Alert
Resources
Tutorial
Gitbook
Team
Aura Insights
Market
Stocks Market
Crypto Market
Terms of Use
Privacy Policy
Sitemap
© 2025 Finture Development Limited. All rights reserved
Ask AI About TCRX
Income
Balance sheet
Cash flow
Annual
Quarterly
TCRX Income
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue
8
2
21
13
10
1
Revenue Growth (YoY)
-11%
-90%
62%
30%
900%
--
Cost of Revenue
--
--
--
--
--
--
Gross Profit
--
--
--
--
--
--
Selling, General & Admin
33
30
26
20
13
6
Research & Development
121
107
88
59
44
20
Operating Expenses
158
137
114
80
58
27
Other Non Operating Income (Expenses)
--
--
--
--
--
--
Pretax Income
-142
-127
-89
-66
-48
-26
Income Tax Expense
--
--
--
--
--
--
Net Income
-142
-127
-89
-66
-48
-26
Net Income Growth
28%
43%
35%
38%
85%
100%
Shares Outstanding (Diluted)
129.83
111.99
65.59
24.05
23.59
23.59
Shares Change (YoY)
9%
71%
173%
2%
0%
0%
EPS (Diluted)
-1.09
-1.13
-1.36
-2.75
-2.06
-1.11
EPS Growth
17%
-16%
-51%
34%
86%
91%
Free Cash Flow
-135
-114
-64
-70
-58
-7
Free Cash Flow Per Share
-1.03
-1.01
-0.97
-2.91
-2.45
-0.29
Gross Margin
--
--
--
--
--
--
Operating Margin
-1,862.5%
-6,700%
-442.85%
-507.69%
-480%
-2,600%
Profit Margin
-1,775%
-6,350%
-423.8%
-507.69%
-480%
-2,600%
Free Cash Flow Margin
-1,687.5%
-5,700%
-304.76%
-538.46%
-580%
-700%
EBITDA
-147
-130
-88
-61
-45
-25
EBITDA Margin
-1,837.5%
-6,500%
-419.04%
-469.23%
-450%
-2,500%
D&A For EBITDA
2
4
5
5
3
1
EBIT
-149
-134
-93
-66
-48
-26
EBIT Margin
-1,862.5%
-6,700%
-442.85%
-507.69%
-480%
-2,600%
Effective Tax Rate
--
--
--
--
--
--
Follow-Up Questions
What are TScan Therapeutics Inc's key financial statements?
What are the key financial ratios for TCRX?
How is TScan Therapeutics Inc's revenue broken down by segment or geography?
Is TScan Therapeutics Inc profitable?
Does TScan Therapeutics Inc have any liabilities?
How many outstanding shares for TScan Therapeutics Inc?
Portfolio
